TwitterLinkedInFacebookInstagram

 | 

SearchSearch
United States

Company Overview

OraSure Technologies transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics.

The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions.

OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers.

Number of Employees: 638 (as of 12/31/23)

Financial Info

Years Ended
(in thousands, except per share amounts)
(Audited)

2023 2022
Revenues $405,472 $387,479
Net Income $53,655 $(17,133)
Earnings per share - Basic
Diluted
$0.73
$0.72
$(0.24)
$(0.24)
Number of shares - Basic
Diluted
73,348
74,389
72,505
72,505

Vision

OraSure Technologies transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are.

Mission

Improving access, quality, and value of healthcare with innovation in effortless tests, sample management solutions, and services.

Corporate Responsibility

OraSure Technologies is committed to being a socially responsible corporate citizen. Not only is it critical to our long-term success, but it is a core component of who we are as a company. Our ability to positively effect change is powered by the innovative tools, services, and diagnostics we deliver to the market, and by being a responsible business, manufacturer, and ethical employer.

OraSure works closely with governmental agencies to obtain product approvals, including FDA and CE registration, and adheres to highly ethical marketing practices. The Company also takes great pride in offering employees competitive wages with comprehensive benefits and minimizing our manufacturing’s impact on the local environment. We honor and respect our responsibility to our national and local community, our environment, our customers, and our employees.

Learn more about our efforts to be a socially responsible company in our OraSure Cares ESG report.

Executive Committee

Carrie Eglinton Manner

Carrie Eglinton Manner

President &
Chief Executive Officer

Kenneth J. McGrath

Kenneth J. McGrath

Chief Financial Officer

Michele Anthony

Michele Anthony

Senior Vice President
Controller & Chief Accounting Officer

Kathleen Weber

Kathleen Weber

Chief Product Officer

David Rappaport

David Rappaport, CFA

Senior Vice President
Corporate Development,
Strategy and Integration

Rafal Iwasiow

Rafal Iwasiow, Ph.D.

Vice President
Science, Innovation & Technology

Amy Steigerwalt

Amy Steigerwalt

Senior Vice President
Human Resources

Zachary Wert

Zachary Wert

Senior Vice President
Global Operations

Stefano Taucer

Stefano Taucer

General Counsel &
Corporate Secretary

TraceCuster

Trace Custer

Senior Vice President
Quality & Regulatory

Board of Directors

Mara G. Aspinall

Mara G. Aspinall

Chair of the Board
Partner, Illumina Ventures

Nancy J. Gagliano

Nancy J. Gagliano, MD, MBA

Managing Director
Granite Healthcare Advisors

Lelio Marmora

Lelio Marmora

Former Executive Director
Unitaid

Carrie Eglinton Manner

Carrie Eglinton Manner

President &
Chief Executive Officer
OraSure Technologies, Inc.

David Shulkin M.D.

David Shulkin, M.D.

President &
Chief Executive Officer
Shulkin Solutions, Inc.

Robert McMahon

Robert W. McMahon

Senior Vice President &
Chief Financial Officer
Agilent Technologies

© OraSure Technologies Inc., 2024